Fischer Quentin, Darmon Arthur, Ducrocq Grégory, Feldman Laurent
Department of Cardiology, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, DHU FIRE, INSERM U-1148, Université de Paris, Paris, France.
Eur Heart J Case Rep. 2020 May 19;4(FI1):1-5. doi: 10.1093/ehjcr/ytaa131. eCollection 2020 Oct.
Coronavirus disease-2019 (COVID-19) is an infectious disease appeared in China in December 2019 and, since then, has spread worldwide at a rapid pace.
A patient with COVID-19 was hospitalized in our institution for a diabetic foot ulcer and presented afterwards a pulmonary oedema and concomitant anterior ST-segment elevation myocardial infarction. We report here on the initial presentation, coronary care and intervention, and clinical course of this patient.
Emergent percutaneous coronary intervention is feasible and safe in COVID-19 patients but requires a multidisciplinary effort involving caregivers from infectious disease, intensive care, and cardiology teams.
2019年冠状病毒病(COVID-19)是一种于2019年12月在中国出现的传染病,自那时起已在全球迅速传播。
一名COVID-19患者因糖尿病足溃疡入住我院,随后出现肺水肿并伴有前壁ST段抬高型心肌梗死。我们在此报告该患者的初始表现、冠心病监护及干预措施以及临床病程。
急诊经皮冠状动脉介入治疗在COVID-19患者中是可行且安全的,但需要传染病、重症监护和心脏病学团队的医护人员进行多学科协作。